Skip to main content
Erschienen in: Rheumatology International 5/2012

01.05.2012 | Original Article

The effect of mud pack therapy on serum YKL-40 and hsCRP levels in patients with knee osteoarthritis

verfasst von: Gonca Güngen, Fusun Ardic, Gülin Fιndıkoğlu, Simin Rota

Erschienen in: Rheumatology International | Ausgabe 5/2012

Einloggen, um Zugang zu erhalten

Abstract

The aim of this study was to evaluate the efficacy of treatment with mud pack in knee osteoarthritis (OA) and to determine whether mud pack effects serum levels of YKL-40 and high-sensitivity C-reactive protein (hsCRP) which are reported to be biological markers for articular damage or inflammation in patients with OA. Forty-four patients with the diagnosis of knee OA assigned into two groups were treated with local natural mineral-rich mud pack or hot pack. Treatments were applied for 6 days a week for 2 weeks as a total of 12 sessions. Patients were assessed at baseline, post-treatment, and 3 months after the treatment. VAS, range of motion, 15-m walking time, WOMAC index, Nottingham Health Profile, serum YKL-40, and hsCRP levels were the outcome measures. Pain intensity and joint stiffness decreased in both groups at all follow-ups. Physical activity status was found to persist for 3 months after treatment only in mud pack group. Serum mean YKL-40 and hsCRP levels of the patients were higher compared to healthy control group. Serum YKL-40 level increased significantly only in hot pack group 3 months after the treatment (P < 0.017). No significant change was observed in hsCRP levels in both groups during the whole follow-up periods (P > 0.05). Mud pack and hot pack therapy were both demonstrated to be effective in symptomatic treatment of knee OA until the end of the 2-week treatment period, whereas only mud pack therapy was shown to be effective in functional status over time. In the hot pack group, increased serum YKL-40 level 3 months after the treatment might indicate persistence of cartilage degradation. Maintenance of YKL-40 level in mud pack therapy seems to slow down the progression of knee OA.
Literatur
1.
2.
Zurück zum Zitat Abe M, Takahashi M, Naitou K, Ohmura K, Nagano A (2003) Investigation of generalized osteoarthritis by combining X-ray grading of the knee, spine and hand using biochemical markers for arthritis in patients with knee osteoarthritis. Clin Rheumatol 22:425–431PubMedCrossRef Abe M, Takahashi M, Naitou K, Ohmura K, Nagano A (2003) Investigation of generalized osteoarthritis by combining X-ray grading of the knee, spine and hand using biochemical markers for arthritis in patients with knee osteoarthritis. Clin Rheumatol 22:425–431PubMedCrossRef
3.
Zurück zum Zitat Garnero P, Ayral X, Rousseau JC, Christgau S, Sandell LJ, Dougados M, Delmas PD (2002) Uncoupling of type II collagen synthesis and degradation predicts progression of joint damage in patients with knee osteoarthritis. Arthritis Rheum 46:2613–2624PubMedCrossRef Garnero P, Ayral X, Rousseau JC, Christgau S, Sandell LJ, Dougados M, Delmas PD (2002) Uncoupling of type II collagen synthesis and degradation predicts progression of joint damage in patients with knee osteoarthritis. Arthritis Rheum 46:2613–2624PubMedCrossRef
4.
Zurück zum Zitat Vignon E, Garnero P, Delmas P et al (2001) Recommendations for the registration of drugs used in the treatment of osteoarthritis: an update on biochemical markers. Osteoarthr Cartil 4:289–293CrossRef Vignon E, Garnero P, Delmas P et al (2001) Recommendations for the registration of drugs used in the treatment of osteoarthritis: an update on biochemical markers. Osteoarthr Cartil 4:289–293CrossRef
5.
Zurück zum Zitat Harvey S, Weisman M, O’Dell J, Scott T, Krusemeier M, Visor J, Swindlehurst C (1998) Chondrex: new marker of joint disease. Clin Chem 44:509–516PubMed Harvey S, Weisman M, O’Dell J, Scott T, Krusemeier M, Visor J, Swindlehurst C (1998) Chondrex: new marker of joint disease. Clin Chem 44:509–516PubMed
6.
Zurück zum Zitat Hakala BE, White C, Recklies AD (1993) Human cartilage gp-39, a major secretory product of articular chondrocytes and synovial cells, is a mammalian member of a chitinase protein family. J Biol Chem 268:25803–25810PubMed Hakala BE, White C, Recklies AD (1993) Human cartilage gp-39, a major secretory product of articular chondrocytes and synovial cells, is a mammalian member of a chitinase protein family. J Biol Chem 268:25803–25810PubMed
7.
Zurück zum Zitat Johansen JS, Hvolris J, Hansen M, Backer V, Lorenzen I, Price PA (1996) Serum YKL-40 levels on healthy children and adults. Comparison with serum and synovial fluid levels of YKL-40 in patients with osteoarthritis or trauma of the knee joint. Br J Rheumatol 35:553–559PubMedCrossRef Johansen JS, Hvolris J, Hansen M, Backer V, Lorenzen I, Price PA (1996) Serum YKL-40 levels on healthy children and adults. Comparison with serum and synovial fluid levels of YKL-40 in patients with osteoarthritis or trauma of the knee joint. Br J Rheumatol 35:553–559PubMedCrossRef
8.
Zurück zum Zitat Volck B, Ostergaard K, Jhansen JS, Garbarsch C, Price PA (1999) The distribution of YKL-40 in osteoarthritic and normal human cartilage. Scand J Rheumatol 28:171–179PubMedCrossRef Volck B, Ostergaard K, Jhansen JS, Garbarsch C, Price PA (1999) The distribution of YKL-40 in osteoarthritic and normal human cartilage. Scand J Rheumatol 28:171–179PubMedCrossRef
9.
Zurück zum Zitat Volck B, Johansen JS, Stoltenberg M et al (2001) Studies on YKL-40 in knee joints of patients with rheumatoid arthritis and osteoarthritis. Involvement of YKL-40 in the joint pathology. Osteoarthr Cartil 9:203–214PubMedCrossRef Volck B, Johansen JS, Stoltenberg M et al (2001) Studies on YKL-40 in knee joints of patients with rheumatoid arthritis and osteoarthritis. Involvement of YKL-40 in the joint pathology. Osteoarthr Cartil 9:203–214PubMedCrossRef
10.
Zurück zum Zitat Conrozier T, Carlier MC, Mathieu P, Colson F, Debard AL, Richard S, Favret H, Bienvenu J, Vignon E (2000) Serum levels of YKL-40 and C reactive protein in patients with hip osteoarthritis and healthy subjects: a cross sectional study. Ann Rheum Dis 59:828–831PubMedCrossRef Conrozier T, Carlier MC, Mathieu P, Colson F, Debard AL, Richard S, Favret H, Bienvenu J, Vignon E (2000) Serum levels of YKL-40 and C reactive protein in patients with hip osteoarthritis and healthy subjects: a cross sectional study. Ann Rheum Dis 59:828–831PubMedCrossRef
11.
Zurück zum Zitat Garnero P, Piperno M, Gineyts E, Christgau S, Delmas PD, Vignon E (2001) Cross sectional evaluation of biochemical markers of bone, cartilage, and synovial tissue metabolism in patients with knee osteoarthritis: relations with disease activity and joint damage. Ann Rheum Dis 60:619–626PubMedCrossRef Garnero P, Piperno M, Gineyts E, Christgau S, Delmas PD, Vignon E (2001) Cross sectional evaluation of biochemical markers of bone, cartilage, and synovial tissue metabolism in patients with knee osteoarthritis: relations with disease activity and joint damage. Ann Rheum Dis 60:619–626PubMedCrossRef
12.
Zurück zum Zitat Connor JR, Dodds RA, Emery JG, Kirkpatrick RB, Rosenberg M, Gowen M (2000) Human cartliage glycoprotein 39 (HC-gp 39) mRNA expression in adult and fetal chondrocytes, osteoblasts and osteocytes by in situ hybridization. Osteoarthr Cartil 8:87–95PubMedCrossRef Connor JR, Dodds RA, Emery JG, Kirkpatrick RB, Rosenberg M, Gowen M (2000) Human cartliage glycoprotein 39 (HC-gp 39) mRNA expression in adult and fetal chondrocytes, osteoblasts and osteocytes by in situ hybridization. Osteoarthr Cartil 8:87–95PubMedCrossRef
13.
Zurück zum Zitat Kawasaki M, Hasegawa Y, Kondo S, Iwata H (2001) Concentration and localization of YKL-40 in hip joint diseases. J Rheumatol 28:341–345PubMed Kawasaki M, Hasegawa Y, Kondo S, Iwata H (2001) Concentration and localization of YKL-40 in hip joint diseases. J Rheumatol 28:341–345PubMed
14.
Zurück zum Zitat Wolfe F (1997) The C-reactive protein but not erythrocyte sedimentation rate is associated with clinical severity in patients with osteoarthritis of the knee or hip. J Rheumatol 8:1486–1488 Wolfe F (1997) The C-reactive protein but not erythrocyte sedimentation rate is associated with clinical severity in patients with osteoarthritis of the knee or hip. J Rheumatol 8:1486–1488
15.
Zurück zum Zitat Sowers M, Jannausch M, Stein E, Jamadar D, Hochberg M, Lachance L (2002) C-reactive protein as a biomarker of emergent osteoarthritis. Osteoarthr Cartil 10:595–601PubMedCrossRef Sowers M, Jannausch M, Stein E, Jamadar D, Hochberg M, Lachance L (2002) C-reactive protein as a biomarker of emergent osteoarthritis. Osteoarthr Cartil 10:595–601PubMedCrossRef
16.
Zurück zum Zitat Sturmer T, Brenner H, Koenig W, Gunther KP (2004) Severity and extent of osteoarthritis and low grade systemic inflammation as assessed by high sensitivity C reactive protein. Ann Rheum Dis 63:200–205PubMedCrossRef Sturmer T, Brenner H, Koenig W, Gunther KP (2004) Severity and extent of osteoarthritis and low grade systemic inflammation as assessed by high sensitivity C reactive protein. Ann Rheum Dis 63:200–205PubMedCrossRef
17.
Zurück zum Zitat Pearle AD, Scanzello CR, George S, Mandl LA, DiCarlo EF, Peterson M, Sculco TP, Crow MK (2007) Elevated high-sensitivity C-reactive protein levels are associated with local inflammatory findings in patients with osteoarthritis. Osteoarthr Cartil 15:516–523PubMedCrossRef Pearle AD, Scanzello CR, George S, Mandl LA, DiCarlo EF, Peterson M, Sculco TP, Crow MK (2007) Elevated high-sensitivity C-reactive protein levels are associated with local inflammatory findings in patients with osteoarthritis. Osteoarthr Cartil 15:516–523PubMedCrossRef
18.
Zurück zum Zitat Lange U, Müller-Lander U, Schmidt KL (2006) Balneotheraphy in rheumatic diseases: an overview of novel and known aspect. Rheumatol Int 26:497–499PubMedCrossRef Lange U, Müller-Lander U, Schmidt KL (2006) Balneotheraphy in rheumatic diseases: an overview of novel and known aspect. Rheumatol Int 26:497–499PubMedCrossRef
19.
Zurück zum Zitat Zhang W, Doherty M, Arden N et al (2005) EULAR evidence based recommendations for the management of hip osteoarthritis: report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 64:669–681PubMedCrossRef Zhang W, Doherty M, Arden N et al (2005) EULAR evidence based recommendations for the management of hip osteoarthritis: report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 64:669–681PubMedCrossRef
20.
Zurück zum Zitat Flusser D, Abu-Shakra M, Friger M, Codish S, Sukenik S (2002) Therapy with mud compresses for knee osteoarthritis: comparison of natural mud preparations with mineral-depleted mud. J Clin Rheumatol 8:197–203PubMedCrossRef Flusser D, Abu-Shakra M, Friger M, Codish S, Sukenik S (2002) Therapy with mud compresses for knee osteoarthritis: comparison of natural mud preparations with mineral-depleted mud. J Clin Rheumatol 8:197–203PubMedCrossRef
21.
Zurück zum Zitat Evcik D, Kavuncu V, Yeter A, Yigit I (2007) The efficacy of balneotherapy and mud-pack therapy in patients with knee osteoarthritis. Joint Bone Spine 74:60–65PubMedCrossRef Evcik D, Kavuncu V, Yeter A, Yigit I (2007) The efficacy of balneotherapy and mud-pack therapy in patients with knee osteoarthritis. Joint Bone Spine 74:60–65PubMedCrossRef
22.
Zurück zum Zitat Codish S, Abu-Shakra M, Flusser D, Friger M, Sukenik S (2005) Mud compress therapy for the hands of patients with rheumatoid arthritis. Rheumatol Int 25:49–54PubMedCrossRef Codish S, Abu-Shakra M, Flusser D, Friger M, Sukenik S (2005) Mud compress therapy for the hands of patients with rheumatoid arthritis. Rheumatol Int 25:49–54PubMedCrossRef
23.
Zurück zum Zitat Sukenik S, Buskila D, Neumann L, Kleiner-Baumgarten A, Zimlichman S, Horowitz J (1990) Sulphur bath and mud pack treatment for rheumatoid arthritis at the Dead Sea area. Ann Rheum Dis 49:99–102PubMedCrossRef Sukenik S, Buskila D, Neumann L, Kleiner-Baumgarten A, Zimlichman S, Horowitz J (1990) Sulphur bath and mud pack treatment for rheumatoid arthritis at the Dead Sea area. Ann Rheum Dis 49:99–102PubMedCrossRef
24.
Zurück zum Zitat Elkayam O, Ophir J, Brener S, Paran D, Wigler I, Efron D, Even-Paz Z, Politi Y, Yaron M (2000) Immediate and delayed effects of treatment at the Dead Sea in patients with psoriatic arthritis. Rheumatol Int 19:77–82PubMedCrossRef Elkayam O, Ophir J, Brener S, Paran D, Wigler I, Efron D, Even-Paz Z, Politi Y, Yaron M (2000) Immediate and delayed effects of treatment at the Dead Sea in patients with psoriatic arthritis. Rheumatol Int 19:77–82PubMedCrossRef
25.
Zurück zum Zitat Fioravanti A, Perpignano G, Tirri G, Cardinale G, Gianniti C, Lanza CE, Loi A, Tirri E, Sfriso P, Cozzi F (2007) Effects of mud-bath treatment on fibromyalgia patients: a randomized clinical trial. Rheumatol Int 27:1157–1161PubMedCrossRef Fioravanti A, Perpignano G, Tirri G, Cardinale G, Gianniti C, Lanza CE, Loi A, Tirri E, Sfriso P, Cozzi F (2007) Effects of mud-bath treatment on fibromyalgia patients: a randomized clinical trial. Rheumatol Int 27:1157–1161PubMedCrossRef
26.
Zurück zum Zitat Sert F (2008) Osteoartrit hastalarında YKL-40 ve yüksek-duyarlıklı CRP (hsCRP) düzeylerinin değerlendirilmesi. Dissertation, University of Pamukkale Sert F (2008) Osteoartrit hastalarında YKL-40 ve yüksek-duyarlıklı CRP (hsCRP) düzeylerinin değerlendirilmesi. Dissertation, University of Pamukkale
27.
Zurück zum Zitat Bellamy N, Buchanan WW, Goldsmith CH, Campbell SLW (1988) Validation of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol 15:1833–1840PubMed Bellamy N, Buchanan WW, Goldsmith CH, Campbell SLW (1988) Validation of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol 15:1833–1840PubMed
28.
Zurück zum Zitat Tüzün EH, Eker L, Aytar A (2005) Acceptability, reliability, validity and responsiveness of the Turkish version of WOMAC osteoarthritis index. Osteoarthr Cartil 13:28–33PubMedCrossRef Tüzün EH, Eker L, Aytar A (2005) Acceptability, reliability, validity and responsiveness of the Turkish version of WOMAC osteoarthritis index. Osteoarthr Cartil 13:28–33PubMedCrossRef
29.
Zurück zum Zitat Martini CJM, Waugh IM (1978) A method for self-assessment of disability before and after hip replacement operation. BMJ 2:258–259 Martini CJM, Waugh IM (1978) A method for self-assessment of disability before and after hip replacement operation. BMJ 2:258–259
30.
Zurück zum Zitat Kucukdeveci AA, McKenna SP, Kutlay S, Gursel Y, Whalley D, Arasil T (2000) The development and psychometric assessment of the Turkish version of the Nottingham health profile. Int J Rehabil Res 23(1):31–38PubMedCrossRef Kucukdeveci AA, McKenna SP, Kutlay S, Gursel Y, Whalley D, Arasil T (2000) The development and psychometric assessment of the Turkish version of the Nottingham health profile. Int J Rehabil Res 23(1):31–38PubMedCrossRef
31.
Zurück zum Zitat Odabaşı E, Turan M, Erdem H, Pay S, Güleç M, Karagülle MZ (2009) The effect of Mud pack treatment in knee osteoarthritis. Turk J Rheumatol 24:72–76 Odabaşı E, Turan M, Erdem H, Pay S, Güleç M, Karagülle MZ (2009) The effect of Mud pack treatment in knee osteoarthritis. Turk J Rheumatol 24:72–76
32.
Zurück zum Zitat Fioravanti A, Iacoponi F, Bellisai B, Cantarini L, Galeazzi M (2010) Short- and long-term effects of spa therapy in knee osteoarthritis. Am J Phys Med Rehabil 89(2):125–132PubMedCrossRef Fioravanti A, Iacoponi F, Bellisai B, Cantarini L, Galeazzi M (2010) Short- and long-term effects of spa therapy in knee osteoarthritis. Am J Phys Med Rehabil 89(2):125–132PubMedCrossRef
33.
Zurück zum Zitat Tolomio C, Ceschi-Berrini C, Moschin E, Galzigna L (1999) Colonization by diatoms and antirheumatic activity of thermal mud. Cell Biochem Funct 17:169–175CrossRef Tolomio C, Ceschi-Berrini C, Moschin E, Galzigna L (1999) Colonization by diatoms and antirheumatic activity of thermal mud. Cell Biochem Funct 17:169–175CrossRef
34.
Zurück zum Zitat Sulenik S, Abu-Shakra M, Flusser D (1997) Balneotheraphy in autoimmun disease. Isr J Med Sci 33:258–261 Sulenik S, Abu-Shakra M, Flusser D (1997) Balneotheraphy in autoimmun disease. Isr J Med Sci 33:258–261
35.
Zurück zum Zitat Ghersetich I, Freedman D, Lotti T (2000) Balneology today. J Eur Acad Dermatol Venereol 14:346–348PubMedCrossRef Ghersetich I, Freedman D, Lotti T (2000) Balneology today. J Eur Acad Dermatol Venereol 14:346–348PubMedCrossRef
36.
Zurück zum Zitat Beer AM, Junginger HE, Lukanov J, Sagorchev P (2003) Evaluation of the permeation of peat substances through human skin in vitro. Int J Pharm 253:169–175PubMedCrossRef Beer AM, Junginger HE, Lukanov J, Sagorchev P (2003) Evaluation of the permeation of peat substances through human skin in vitro. Int J Pharm 253:169–175PubMedCrossRef
37.
Zurück zum Zitat Beer AM, Lukanov J, Sagorchev P (2000) Mechanism of the effect of aqueous peat extract on spontaneous contractile activity of smooth muscles. Forsch Komplementärmed Klass Naturheilkd 7:237–241PubMedCrossRef Beer AM, Lukanov J, Sagorchev P (2000) Mechanism of the effect of aqueous peat extract on spontaneous contractile activity of smooth muscles. Forsch Komplementärmed Klass Naturheilkd 7:237–241PubMedCrossRef
38.
Zurück zum Zitat Odabasi E, Turan M, Erdem H, Tekbas F (2008) Does mud pack treatment have any effect? A randomized controlled clinical study. J Altern Complement Med 14:559–565PubMedCrossRef Odabasi E, Turan M, Erdem H, Tekbas F (2008) Does mud pack treatment have any effect? A randomized controlled clinical study. J Altern Complement Med 14:559–565PubMedCrossRef
39.
Zurück zum Zitat Cechettin M, Bellometti S, Lalli A, Galzigna L (1995) Serum interleukin-1 changes in arthrosis patients after mud-pack treatment. Phys Rehab Kur Med 5:92–93CrossRef Cechettin M, Bellometti S, Lalli A, Galzigna L (1995) Serum interleukin-1 changes in arthrosis patients after mud-pack treatment. Phys Rehab Kur Med 5:92–93CrossRef
40.
Zurück zum Zitat Bellometti S, Galzigna L (1998) Serum levels of a prostaglandin and a leukotriene after thermal mud pack therapy. J Investig Med 46:140–145PubMed Bellometti S, Galzigna L (1998) Serum levels of a prostaglandin and a leukotriene after thermal mud pack therapy. J Investig Med 46:140–145PubMed
41.
Zurück zum Zitat Bellometti S, Richelmi P, Tassoni T et al (2005) Production of matrix metalloproteinases and their inhibitors in osteoarthritic patients undergoing mud-bath therapy. Int J Clin Pharmacol Res 25:77–94PubMed Bellometti S, Richelmi P, Tassoni T et al (2005) Production of matrix metalloproteinases and their inhibitors in osteoarthritic patients undergoing mud-bath therapy. Int J Clin Pharmacol Res 25:77–94PubMed
42.
Zurück zum Zitat Bellometti S, Galzigna L, Richelmi P et al (2002) Both serum receptors of tumor necrosis factor are influenced by mud-pack treatment in osteoarthritic patients. Int J Tissue React 24:57–64PubMed Bellometti S, Galzigna L, Richelmi P et al (2002) Both serum receptors of tumor necrosis factor are influenced by mud-pack treatment in osteoarthritic patients. Int J Tissue React 24:57–64PubMed
43.
Zurück zum Zitat Bellometti S, Giannini S, Sartori L, Crepaldi G (1997) Cytokine levels in osteoarthrosis patients undergoing mud bath therapy. Int J Clin Pharmacol Res 17:149–153PubMed Bellometti S, Giannini S, Sartori L, Crepaldi G (1997) Cytokine levels in osteoarthrosis patients undergoing mud bath therapy. Int J Clin Pharmacol Res 17:149–153PubMed
44.
Zurück zum Zitat Bellometti S, Cecchettin M, Galzigna L (1997) Mud pack therapy in osteoarthrosis: changes in serum levels of chondrocyte markers. Clin Chim Acta 268:101–106PubMedCrossRef Bellometti S, Cecchettin M, Galzigna L (1997) Mud pack therapy in osteoarthrosis: changes in serum levels of chondrocyte markers. Clin Chim Acta 268:101–106PubMedCrossRef
45.
Zurück zum Zitat Bellometti S, Poletto M, Gregotti C, Richelmi P, Berte F (2000) Mud bath therapy influences nitric oxide, myeloperoxidase and glutathione peroxidase serum levels in arthritic patients. Int J Clin Pharmacol Res 20(3–4):69–80PubMed Bellometti S, Poletto M, Gregotti C, Richelmi P, Berte F (2000) Mud bath therapy influences nitric oxide, myeloperoxidase and glutathione peroxidase serum levels in arthritic patients. Int J Clin Pharmacol Res 20(3–4):69–80PubMed
46.
Zurück zum Zitat Swaak AJ, van Rooyen A, Nieuwenhuis E, Aarden LA (1988) Interleukin-6 (IL-6) in synovial fluid and serum of patients with rheumatic diseases. Scand J Rheumatol 17:469–474PubMedCrossRef Swaak AJ, van Rooyen A, Nieuwenhuis E, Aarden LA (1988) Interleukin-6 (IL-6) in synovial fluid and serum of patients with rheumatic diseases. Scand J Rheumatol 17:469–474PubMedCrossRef
47.
Zurück zum Zitat Abramson SB, Attur M, Amin AR, Clancy R (2001) Nitric oxide and inflammatory mediators in the perpetuation of osteoarthritis. Curr Rheumatol Rep 3:535–541PubMedCrossRef Abramson SB, Attur M, Amin AR, Clancy R (2001) Nitric oxide and inflammatory mediators in the perpetuation of osteoarthritis. Curr Rheumatol Rep 3:535–541PubMedCrossRef
48.
Zurück zum Zitat Westacott CI, Whicher JT, Barnes IC, Thompson D, Swan AJ, Dieppe PA (1990) Synovial fluid concentration of five different cytokines in rheumatic diseases. Ann Rheum Dis 49:676–681PubMedCrossRef Westacott CI, Whicher JT, Barnes IC, Thompson D, Swan AJ, Dieppe PA (1990) Synovial fluid concentration of five different cytokines in rheumatic diseases. Ann Rheum Dis 49:676–681PubMedCrossRef
49.
Zurück zum Zitat Guerne PA, Zuraw BL, Vaughan JH, Carson DA, Lotz M (1989) Synovium as a source of interleukin 6 in vitro. Contribution to local and systemic manifestations of arthritis. J Clin Invest 83:585–592PubMedCrossRef Guerne PA, Zuraw BL, Vaughan JH, Carson DA, Lotz M (1989) Synovium as a source of interleukin 6 in vitro. Contribution to local and systemic manifestations of arthritis. J Clin Invest 83:585–592PubMedCrossRef
50.
Zurück zum Zitat Ridker PM (2001) High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Circulation 103:1813–1818PubMed Ridker PM (2001) High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Circulation 103:1813–1818PubMed
Metadaten
Titel
The effect of mud pack therapy on serum YKL-40 and hsCRP levels in patients with knee osteoarthritis
verfasst von
Gonca Güngen
Fusun Ardic
Gülin Fιndıkoğlu
Simin Rota
Publikationsdatum
01.05.2012
Verlag
Springer-Verlag
Erschienen in
Rheumatology International / Ausgabe 5/2012
Print ISSN: 0172-8172
Elektronische ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-010-1727-4

Weitere Artikel der Ausgabe 5/2012

Rheumatology International 5/2012 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.